Six claims, six designs: NU670's Unit 4 evidence strength table sorts the inflammation account of depression by study type, from endotoxin challenge in volunteers to randomized trials of anti-inflammatory treatment. Searches like "nu 670 unit 4 assignment example", "nu670 unit 4 sample" and "nu670 unit 4 example" land here.
What a finished NU670 Unit 4 evidence strength table looks like
Six rows, six columns, then a page of interpretation. Columns give the claim, the key study, design, species and sample, what the design can establish, and a strength rating. Row one: depressed adults show higher average IL-6 and TNF-alpha, from case-control meta-analysis (Dowlati et al., 2010), rated association only. Row two: roughly a quarter of depressed patients have low-grade inflammation (Osimo et al., 2019). Row three: interferon-alpha therapy induces depressive symptoms, and paroxetine pretreatment reduced them in a small randomized trial (Musselman et al., 2001). Row four: endotoxin given to healthy volunteers lowers mood and blunts ventral striatal reward response (Eisenberger et al., 2010). Row five: infliximab showed no overall benefit, with a possible effect in high-CRP patients (Raison et al., 2013). Row six: TSPO imaging suggests microglial activation (Setiawan et al., 2015).
How a NU670 Unit 4 example is structured
A two-sentence introduction states the headline claim and explains why it has to be split: association, induction, mechanism and treatment effect are different questions answered by different designs. The table follows immediately, since the table is the deliverable and the prose serves it. Rows are ordered from weakest to strongest design within each question, so a reader scanning down sees evidence accumulate. The strength column uses a stated scale defined in a footnote rather than adjectives invented per row. The interpretation page takes the rows in groups: what the association data show and do not show about direction, what the experimental induction studies add, and why the treatment row is the weakest link for a causal claim despite being the most clinically relevant. A final paragraph restates the headline as the evidence would allow it to be written. Sources are primary studies and meta-analyses, each cited once.
One headline, six questions
The introduction separates the claim into association, prevalence, induction, reward effects, treatment response and cellular mechanism. Splitting it this way lets each part be judged by the design suited to it.
A defined strength scale
Ratings follow a footnoted scale, from single small study to replicated meta-analysis, rather than adjectives chosen row by row. Consistent ratings make the table comparable and defensible if a grader questions one.
Induction as the strongest causal clue
Interferon and endotoxin studies deliberately raise inflammation and observe mood change. The interpretation explains why these experiments speak to causation more directly than any association study can, while noting their small samples.
The treatment row as a test
If inflammation drives depression, reducing it should help. The table reports that infliximab did not help overall and that the high-CRP subgroup finding was exploratory, which makes this the row that most constrains the headline.
The headline rewritten
The final paragraph restates the claim in the form the rows support: inflammation is associated with depression, can induce depressive symptoms experimentally, and may matter most in an inflamed subgroup whose treatment benefit is unproven.
Where marks go in NU670 Unit 4
A column of citations with no design, species or sample size makes the weakest possible version of this table, because nobody reading it can judge strength at all. Strength ratings assigned by impression, with no stated scale, come next, since graders test whether a strong rating could be defended. Treating the association meta-analyses as proof of causation draws the most frequent comment in the interpretation section. Omitting the negative treatment trial, or reporting the subgroup effect as a finding rather than an exploratory result, costs credit for selective reporting. Microglial imaging presented without the caveat that TSPO is not specific to microglia draws a correction. Minor deductions follow from secondary sources replacing the meta-analyses, from tables that break across pages without repeated headers, and from composite patients inserted where none is needed.
Get a NU670 Unit 4 example written to your instructions
An evidence table depends on its claim and its scale, so send the claim your Unit 4 prompt tests and any strength scale your section supplies, plus the rubric. Built to those instructions, the first table is free within 24-48h: each claim split into questions a design can answer, every study classified by design, species and size, and ratings on a footnoted scale.
NU670 Unit 4 questions, answered
Which evidence hierarchy should the table use?
Whichever your section specifies, and if none is given, a standard hierarchy adapted for mechanism questions works well. State it in a footnote. For biological claims, a well-designed experimental study in people can be more informative about causation than a large observational meta-analysis, so explain any departure from a simple ranking.
Can animal studies appear in the table?
Yes, in their own rows and clearly labeled. Rodent studies of inflammation-induced sickness behavior show mechanisms that cannot ethically be tested in people, and leaving them out would weaken the mechanistic rows. Rate them for what they establish in animals and note separately how far that extends to humans.
How many studies per claim are enough?
Usually one key study per row, chosen because it is the strongest or most cited design for that claim, with a meta-analysis preferred where one exists. Adding several studies per row makes the table hard to read. If the evidence conflicts, cite the best study on each side in the same row and rate the row accordingly.